Holen Sie sich die Stockscreener-App
309.05
0.24%
-0.73
Handel nachbörslich:
309.05
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$309.78
Offen:
$308.29
24-Stunden-Volumen:
1.16M
Relative Volume:
0.87
Marktkapitalisierung:
$58.98B
Einnahmen:
$328.68B
Nettoeinkommen (Verlust:
$2.55B
KGV:
23.71
EPS:
13.0349
Netto-Cashflow:
$1.56B
1W Leistung:
+0.69%
1M Leistung:
-8.12%
6M Leistung:
-4.85%
1J Leistung:
+0.16%
1-Tages-Spanne:
$302.14
$310.43
1-Wochen-Bereich:
$295.01
$313.02
52-Wochen-Spanne:
$244.82
$377.54
Cencora Inc Stock (COR) Company Profile
Firmenname
Cencora Inc
Sektor
Branche
Telefon
610-727-7000
Adresse
1 WEST FIRST AVENUE, CONSHOHOCKEN
Compare COR vs MCK, CAH, HSIC, AHG
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
COR
Cencora Inc
|
309.05 | 58.57B | 328.68B | 2.55B | 1.56B | 13.03 |
MCK
Mckesson Corp
|
902.28 | 101.04B | 403.43B | 5.10B | 5.41B | 38.47 |
CAH
Cardinal Health Inc
|
228.30 | 50.99B | 250.74B | 1.55B | 4.39B | 6.5398 |
HSIC
Henry Schein Inc
|
84.88 | 9.63B | 13.38B | 418.00M | 391.00M | 3.3112 |
AHG
Akso Health Group Adr
|
1.15 | 642.53M | 14.85M | -136.07M | 7.25M | -0.4726 |
Cencora Inc Stock (COR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-29 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2026-01-22 | Hochstufung | Jefferies | Hold → Buy |
| 2025-12-09 | Eingeleitet | Barclays | Overweight |
| 2025-06-03 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-12-04 | Fortgesetzt | Mizuho | Outperform |
| 2024-09-18 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-12-14 | Eingeleitet | Wells Fargo | Equal Weight |
| 2023-03-31 | Eingeleitet | Citigroup | Buy |
| 2023-01-31 | Fortgesetzt | Evercore ISI | Outperform |
| 2022-10-11 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-08-22 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2022-07-11 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-06-07 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2022-05-26 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2022-04-12 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-03-12 | Fortgesetzt | Evercore ISI | In-line |
| 2021-02-04 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2021-02-02 | Hochstufung | Cowen | Market Perform → Outperform |
| 2021-01-06 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2021-01-06 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-12-10 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2020-12-03 | Eingeleitet | Mizuho | Neutral |
| 2020-08-06 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-07-15 | Eingeleitet | Barclays | Underweight |
| 2020-06-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-04-23 | Fortgesetzt | Credit Suisse | Outperform |
| 2020-04-16 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2020-04-13 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-04-01 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-03-17 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-02-11 | Herabstufung | BofA/Merrill | Buy → Underperform |
| 2020-02-07 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Hold |
| 2019-07-10 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2019-04-11 | Eingeleitet | Guggenheim | Buy |
| 2019-04-10 | Herabstufung | BofA/Merrill | Buy → Underperform |
| 2019-04-10 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2019-02-11 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2019-01-17 | Eingeleitet | UBS | Buy |
| 2018-12-10 | Herabstufung | Jefferies | Buy → Hold |
| 2018-10-26 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2018-09-20 | Eingeleitet | Berenberg | Buy |
| 2018-07-17 | Fortgesetzt | Stifel | Hold |
| 2018-04-09 | Eingeleitet | MoffettNathanson | Buy |
| 2018-03-12 | Hochstufung | KeyBanc Capital Mkts | Sector Weight → Overweight |
| 2018-03-12 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2017-09-25 | Eingeleitet | JP Morgan | Neutral |
| 2017-09-22 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Cencora Inc Aktie (COR) Neueste Nachrichten
Cencora Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Cencora stock after-hours at EUR 54.63: plus 0.11 percent versus prior close - AD HOC NEWS
Cencora stock pre-market at EUR 54.84: plus 0.49 percent - AD HOC NEWS
Cencora Inc. stock outperforms competitors on strong trading day - MarketWatch
ETFs Investing in Cencora, Inc. Stocks - TradingView
Cencora elects Ryder executive Sanchez to board of directors - Pennsylvania Business Report -
Cencora Inc. stock outperforms competitors despite losses on the day - MarketWatch
$100 Invested In Cencora 5 Years Ago Would Be Worth This Much Today - Benzinga
Cencora stock last trades at USD 305.26 on September 28, 2026 - AD HOC NEWS
Cencora Inc Lobbyists, 2014 - OpenSecrets
Cencora Inc Agencies, 2024 - OpenSecrets
Form 8K Cencora Inc For: 25 September By Investing.com - Investing.com Nigeria
Cencora Elects Former Ryder CEO Robert Sanchez to Board - citybiz
Cencora appoints former Ryder CEO to board of directors By Investing.com - Investing.com India
Cencora, Inc. Announces Appointment of Robert E. Sanchez as Independent Director, Effective October 1, 2026 - marketscreener.com
Robert E. Sanchez appointed to Cencora board effective Oct 1, 2026 - TradingView
Cencora appoints former Ryder CEO to board of directors - Investing.com
Cencora Elects Robert E. Sanchez to Its Board of Directors - marketscreener.com
Cencora (COR) Stock Forecast and Price Target 2026 $COR - MarketBeat
Cencora stock heads into the open after closing flat - AD HOC NEWS
Cencora (COR) Conference Updates Keep Undervalued Case In Focus - simplywall.st
Cencora stock trades at USD 314.64 below its yearly high - AD HOC NEWS
Cencora stock holds near USD 316 after strong quarterly results - AD HOC NEWS
Cencora stock holds at USD 308.78 as specialty growth supports outlook - AD HOC NEWS
Cencora stock heads into the open after a 1.5 percent market-led gain - AD HOC NEWS
Cencora stock gains as specialty strategy supports fiscal 2027 outlook - AD HOC NEWS
Cencora Sees Specialty Strategy Fueling Growth Into Fiscal 2027 - Yahoo Finance
Cencora Highlights Specialty Growth, MSO Expansion and Walgreens Ties at Conference - Yahoo Finance
Cencora, Inc. (COR) Stock Analysis: Unveiling a 19.6% Potential Upside in the Healthcare Distribution Sector - DirectorsTalk Interviews
Cencora (COR) Lifts EPS Outlook And Buyback, Is The Stock Still Below Fair Value? - Yahoo Finance
Cencora Inc. stock gains after raising full-year EPS guidance - AD HOC NEWS
Cencora (COR) Raised Guidance and Bought Back $1B. What’s the Catch? - Yahoo Finance
What Makes the Latest Cencora (COR) Story Different? - kalkinemedia.com
Cencora Inc. stock eases after insider sale while earnings grow - AD HOC NEWS
Cencora Inc. stock eases after recent insider share sale - AD HOC NEWS
Cencora, Inc. (COR) Stock Forecasts - Yahoo Finance
Cencora (NYSE: COR) director sells $411K in shares - Stock Titan
Cencora Inc. stock gains after beating quarterly earnings estimates - AD HOC NEWS
Cencora Inc Hired Firms, 2026 - OpenSecrets
Cencora (NYSE: COR) director files notice for potential stock sale via Merrill Lynch - Stock Titan
Cencora, Inc. (COR) Stock Analysis: Strong Buy Ratings And A 14.85% Upside Potential - DirectorsTalk Interviews
$1000 Invested In Cencora 10 Years Ago Would Be Worth This Much Today - Benzinga
Cencora (COR) ex-officer lines up new stock sale - Stock Titan
Cencora stock heads into the open after a 0.1% dip - ad-hoc-news.de
Is Cencora (COR) Still Undervalued On Higher 2026 Guidance And Strong Q3 Earnings? - Yahoo Finance
Cencora Inc. stock dips after RBC reiterates cautious price target - ad-hoc-news.de
Is Cencora Stock Underperforming the Dow? - Yahoo Finance
Cencora stock price target maintained at $330 by RBC Capital By Investing.com - Investing.com Australia
Cencora stock heads into the open after a modest decline - ad-hoc-news.de
Cencora stock holds firm after RBC keeps $330 target - ad-hoc-news.de
Cencora Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Finanzdaten der Cencora Inc-Aktie (COR)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.78%
0.38%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):